Medical Device Grade-SH MDI

Sodium Hyaluronate is a polysaccharide molecule, also known as hyaluronic acid. Synthesized by human cells and found in animals, it is a natural component of most connective tissues, such as synovial fluid and the vitreous humor of the eye. It participates in tissue moisturizing and structural support, and provides viscoelasticity, thus acting as a lubricant and shock absorber. Focusfreda's Medical Device Grade-SH MDI product is an injectable grade of sodium hyaluronate, a medical device-grade raw material suitable for use in Ophthalmic Viscoelastic Devices (OVDs), Dermal Fillers, Skin Booster Injections, Surgical Anti- Adhesion Products.

Its Efficacy Includes:

① Moisturizing and improving skin condition

② Repairing wrinkles and folds, enhancing facial aesthetics

③ Preventing postoperative adhesions

④ Inhibiting scar formation; promoting skin wound healing

Product Advantages:

①Product features - Biocompatibility - It is a naturally occurring substance in the human body, with no inflammatory or toxic side effects, exhibiting high biocompatibility and minimal adverse reactions.

②Product features - Biodegradability - The human body possesses enzymes that break down sodium hyaluronate; it can be degraded and absorbed by the body after use.

③Product Characteristics - Product Compliance - This product is manufactured in accordance with CEP and GMP requirements and completed in an independent, advanced sterile workshop. Impurity control is strictly implemented according to European Pharmacopoeia standards.

④Product Characteristics - High Stability - Remains stable under recommended storage and transportation conditions.

Based on the intended use information provided by the customer, FocusFreda's business manager will recommend the most suitable product type.

FocusFreda is a leading global manufacturer specializing in the fermentation production of sodium hyaluronate, supplying high-purity sodium hyaluronate to the cosmetics, nutritional supplement, and medical aesthetics industries in over 70 countries and regions.

Its pharmaceutical-grade sodium hyaluronate API produced through bio-fermentation has obtained EU CEP certification. The company's ESG-compliant factory focuses on resource efficiency and emission reduction, ensuring a stable and sustainable supply of high-quality sodium hyaluronate.